Trial intelligence / Profile preview

Duloxetine for pain in Parkinson's disease patients with depression

jRCTs061180028Completed

Sponsor
Shionogi & Co., Ltd.
Start
May 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Parkinson's disease (PD), major depressive disorder (MDD) and pain comparing Duloxetine with Placebo (2 arms). Primary endpoint: Visual analogue scale. Started May 2015; status: completed.

02

Drugs

duloxetine
03

Conditions

Parkinson's disease (PD)major depressive disorder (MDD)pain

Beyond the preview

Go deeper on jRCTs061180028.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs061180028.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call